Beyond hazard ratios: appropriate statistical methods for quantifying the clinical effectiveness of immune-oncology therapies – the example of the Netherlands

Abstract Background The Dutch Committee for the Evaluation of Oncological Drugs evaluates the effectiveness of new oncological treatments. The committee compares survival endpoints to the so-called PASKWIL-2023 criteria for palliative treatments, which define if treatment effects are considered clin...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Isaac Corro Ramos, Venetia Qendri, Maiwenn Al
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-10-01
Serija:	BMC Medical Research Methodology
Teme:	Immunotherapies Oncology Proportional hazards Weighted log-rank test Restricted mean survival time Hazard ratio
Online dostop:	https://doi.org/10.1186/s12874-024-02373-5
Oznake:	Označite Brez oznak, prvi označite!